Revenue - Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 59.11 CNY -0.94%

Updated:

Hangzhou Tigermed Consulting Co Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Hangzhou Tigermed Consulting Co Ltd
Revenue Peer Comparison

603259

300759

2269

1548

M

688114

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Hangzhou Tigermed Consulting Co Ltd SZSE:300347	Revenue ¥7.4B	CAGR 3-Years 32%	CAGR 5-Years 26%	CAGR 10-Years 36%
	WuXi AppTec Co Ltd SSE:603259	Revenue ¥40.3B	CAGR 3-Years 35%	CAGR 5-Years 33%	CAGR 10-Years N/A
	Pharmaron Beijing Co Ltd SZSE:300759	Revenue ¥11.5B	CAGR 3-Years 31%	CAGR 5-Years 32%	CAGR 10-Years N/A
	WuXi Biologics (Cayman) Inc HKEX:2269	Revenue ¥17B	CAGR 3-Years 45%	CAGR 5-Years 46%	CAGR 10-Years N/A
	Genscript Biotech Corp HKEX:1548	Revenue $839.5m	CAGR 3-Years 29%	CAGR 5-Years 29%	CAGR 10-Years N/A
M	MGI Tech Co Ltd SSE:688114	Revenue ¥4.2B	CAGR 3-Years 57%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Hangzhou Tigermed Consulting Co Ltd's Revenue amounts to 7.4B CNY.

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Hangzhou Tigermed Consulting Co Ltd have been 32% over the past three years , 26% over the past five years , and 36% over the past ten years .

Join more than 134,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.